Baxter International (BAX)
(Delayed Data from NYSE)
$35.69 USD
-0.26 (-0.72%)
Updated May 10, 2024 04:00 PM ET
After-Market: $35.69 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth B Momentum A VGM
Price, Consensus and EPS Surprise
BAX 35.69 -0.26(-0.72%)
Will BAX be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for BAX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BAX
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
BAX: What are Zacks experts saying now?
Zacks Private Portfolio Services
Compared to Estimates, Baxter (BAX) Q1 Earnings: A Look at Key Metrics
Baxter (BAX) Q1 Earnings Beat Estimates, '24 EPS View Raised
Baxter International (BAX) Q1 Earnings and Revenues Surpass Estimates
Other News for BAX
U.S. dialysis volumes expected to rebound in 2024 despite GLP-1 impact
Baxter downgraded to hold by TD Cowen in wake of selloff
Warner Bros. upgraded, Cerence downgraded: Wall Street's top analyst calls
Baxter just downgraded at TD Cowen, here's why
A Glimpse Into The Expert Outlook On Baxter Intl Through 4 Analysts